Neuroblastoma, childhood cancer survivorship, and reducing the consequences of cure

Bone Marrow Transplantation

Volumn 40, Issue 8, 2007, Pages 721-722

  Gurney, J G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARBOPLATIN; CISPLATIN; PLATINUM COMPLEX;

ACUTE LYMPHOBLASTIC LEUKEMIA; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CANCER SURVIVOR; CHILDHOOD CANCER; COGNITIVE DEFECT; DISTRESS SYNDROME; EDITORIAL; GONADAL DISEASE; HEARING LOSS; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; LONG TERM CARE; MULTIMODALITY CANCER THERAPY; MYELOABLATIVE CONDITIONING; NEUROBLASTOMA; NEUROSURGERY; OTOTOXICITY; PRIORITY JOURNAL; QUALITY OF LIFE; SELF CARE; SURVIVAL RATE; TREATMENT PLANNING; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LONG-TERM CARE; NEUROBLASTOMA; QUALITY OF LIFE; SURVIVORS; WHOLE-BODY IRRADIATION;

EID: 34948852724     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705815     Document Type: Editorial

References (20)

1. Reaman GH. Pediatric cancer research from past successes through collaboration to future transdisciplinary research. J Pediatr Oncol Nurs 2004; 21: 123-127.
2. Matthay KK, Cheung NK. High risk neuroblastoma. In: Cheung NK, Cohn SL (eds). Neuroblastoma. Springer: Berlin, 2005, pp 138-149.
3. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341: 1165-1173.
4. Trahair TN, Vowels MR, Johnston K, Cohn RJ, Russell SJ, Neville KA et al. Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation. Bone Marrow Transplant 2007; 40: 741-746.
5. Hewitt M, Greenfield S, Stovall E, and the Institute of Medicine's Committee on Cancer Survivorship (eds). From Cancer Patient to Cancer Survivor: Lost in Transition. The National Academies Press: Washington, DC, 2005.
6. Ness KK, Gurney JG. Adverse late effects of childhood cancer and its treatment on health and performance. Annu Rev Public Health 2007; 28: 279-302.
7. Meadows AT. Pediatric cancer survivorship: Research and clinical care. J Clin Oncol 2006; 24: 5160-5165.
8. Gilmer-Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 2005; 23: 8588-8596.
9. Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors - a report from the Children's Oncology Group. Pediatrics (in press).
10. Kushner BH, Budnick AS, Kramer K, Modak S, Cheung NKV. Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer 2006; 107: 417-422.
11. Parsons SK, Neault MW, Lehmann LE, Brenna LL, Eickhoff, CE, Kretschmar CS et al. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant 1998; 22: 669-674.
12. Punnett A, Bliss B, Dupuis LL, Abdolell M, Doyle J, Sung L. Ototoxicity following pediatric hematopoietic stem cell transplantation: A prospective cohort study. Pediatr Blood Cancer 2004; 42: 598-603.
13. Laverdiere C, Cheung NK, Kushner BH, Kramer K, Modak S, LaQuaglia MP et al. Long-term complications in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer 2005; 45: 324-332.
14. Laverdiere C, Gurney JG, Sklar CA. Late effects of treatment. In: Cheung NK, Cohn SL (eds). Neuroblastoma. Springer: Berlin, 2005, pp 277-288.
15. Barr RD, Chalmers D, De. Pauw S, Furlong W, Weitzman S, Feeny D. Health-related quality of life in survivors of Wilms' tumor and advanced neuroblastoma: A cross-sectional study. J Clin Oncol 2000; 18 3280-3287.
16. Nathan PC, Ness KK, Greenberg ML, Hudson M, Wolden S, Davidoff A et al. Health-related quality of life in adult survivors of childhood Wilms tumor or neuroblastoma: A report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2006 (July 7, E-pub ahead of print).
17. Friedman DL, Freyer DR, Levitt GA. Models of care for survivors of childhood cancer. Pediatr Blood Cancer 2006; 46: 159-168.
18. Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R et al. Childhood cancer survivors' knowledge about their past diagnosis and treatment: Childhood Cancer Survivor study. JAMA 2002; 287: 1832-1839.
19. Landier W, Wallace WH, Hudson MM. Long-term follow-up of pediatric cancer survivors: Education, surveillance, and screening. Pediatr Blood Cancer 2006; 46: 149-158.
20. Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL et al. Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004; 22: 4979-4990.